BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Policy

  Government Adds Additional Charges Against Elizabeth Holmes Ahead of October Trial

  The government has added additional charges of conspiracy, wire fraud, and forfeiture.

  May 12, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  VIVEX to Expand Footprint in Florida to Support Regenerative Medicine Technologies

  The company plans to open a new 90,000 square foot facility this summer. It was a facility that VIVEX’s employees helped design in order to make it as efficient as possible.

  May 12, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  FDA

  Report: NDA, BLA Approvals by the FDA Fell 16% in 2019

  A new report released on Tuesday by GlobalData suggested that there was a 16% decrease in new drug approvals (NDAs) by the U.S. Food and Drug Administration last year.

  May 12, 2020

   · 

  2 min read

   · 

  Krystle Vermes
• 

  Drug Development

  Biopharma Update on the Novel Coronavirus: May 12

  Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 12, 2020.

  May 12, 2020

   · 

  3 min read

   · 

  BioSpace Editorial Staff
• 

  BioCapital

  CEPI Backs Novavax’s COVID-19 Vaccine Candidate with $384 Million

  Novavax secured the funding from the Coalition for Epidemic Preparedness Innovations to further develop the vaccine candidate as well as support a rapid scale-up of manufacturing to support the vaccine, should it prove to be effective.

  May 12, 2020

   · 

  3 min read

   · 

  Alex Keown
• 

  Career Advice

  4 Ways to Address a Career Change

  Going through a career transition can be stressful and difficult to navigate. Many professionals don’t know how to start the process or begin to explain the reasoning for making a shift.

  May 12, 2020

   · 

  3 min read

   · 

  Porschia Parker-Griffin
• 

  Biotech Bay

  Kriya Therapeutics to Focus on Gene Therapy with $80.5M in Funding

  The company, which was founded in 2019, has a pipeline that includes multiple AAV-based gene therapies for the treatment of type 1 and type 2 diabetes, as well as obesity.

  May 12, 2020

   · 

  3 min read

   · 

  Krystle Vermes
• 

  Drug Development

  Genfit’s NASH Drug Falls Short in Late-Stage Clinical Trial

  They expect to share the complete findings with regulators in the upcoming months and make a final decision on whether to continue the clinical trial.

  May 12, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  AMAG Pharma to Lay Off 140 Staffers as Part of Company Restructure

  The restructuring is related to the planned divestiture of Intrarosa (prasterone) and Vyleesi (bremelanotide injection) and the impact of the COVID-19 pandemic.

  May 12, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Skyhawk’s RNA Splicing Tech Draws in Expanded Merck Deal

  The two companies are working to develop and commercialize a particular type of therapy built on modulating RNA splicing using Skyhawk’s SkySTAR technology platform.

  May 12, 2020

   · 

  3 min read

   · 

  Mark Terry